chr1-78627976-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006820.4(IFI44L):c.61A>T(p.Asn21Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000441 in 1,611,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006820.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IFI44L | NM_006820.4 | c.61A>T | p.Asn21Tyr | missense_variant | 2/9 | ENST00000370751.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IFI44L | ENST00000370751.10 | c.61A>T | p.Asn21Tyr | missense_variant | 2/9 | 1 | NM_006820.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000607 AC: 15AN: 247294Hom.: 0 AF XY: 0.0000373 AC XY: 5AN XY: 133896
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1458968Hom.: 0 Cov.: 30 AF XY: 0.0000165 AC XY: 12AN XY: 725712
GnomAD4 genome AF: 0.000263 AC: 40AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.000283 AC XY: 21AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.61A>T (p.N21Y) alteration is located in exon 2 (coding exon 1) of the IFI44L gene. This alteration results from a A to T substitution at nucleotide position 61, causing the asparagine (N) at amino acid position 21 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at